Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice

被引:0
作者
Berta Laquente
Teresa Macarulla
Cristina Bugés
Marta Martín
Carlos García
Carles Pericay
Sandra Merino
Laura Visa
Teresa Martín
Manuela Pedraza
Beatriz Carnero
Raquel Guardeño
Helena Verdaguer
Alejandro Mut
David Vilanova
Adelaida García
机构
[1] Institut Catala d’Oncologia,
[2] Hospital Duran i Reynals,undefined
[3] Hospitalet de Llobregat,undefined
[4] Vall d’Hebrón University Hospital and Vall d’Hebrón Institute of Oncology (VHIO),undefined
[5] Institut Català d’Oncologia (ICO) – Hospital Germans Trias i Pujol,undefined
[6] Hospital de Sant Pau,undefined
[7] Complejo Hospitalario de Burgos,undefined
[8] Corporació Sanitaria Parc Taulí,undefined
[9] Hospital Sant Joan de Reus,undefined
[10] Hospital del Mar,undefined
[11] Hospital Universitario de Salamanca,undefined
[12] Complejo Asistencial Universitario de León,undefined
[13] Hospital El Bierzo,undefined
[14] Institut Català d’Oncologia (ICO),undefined
[15] Celgene S.L.U,undefined
来源
BMC Palliative Care | / 19卷
关键词
Pancreatic Cancer; Health-related quality of life; Cancer chemotherapy; Performance status; EORTC QLQ-C30;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 181 条
[1]  
Carrato A(2015)A systematic review of the burden of pancreatic Cancer in Europe: real-world impact on survival, quality of life and costs J Gastrointest Cancer 46 201-211
[2]  
Falcone A(2016)Pancreatic cancer Nat Rev Dis Prim 2 16022-1302
[3]  
Ducreux M(2017)Supportive care in pancreatic ductal adenocarcinoma Clin Transl Oncol 19 1293-39
[4]  
Valle JW(2018)The importance of quality-of-life management in patients with advanced pancreatic ductal adenocarcinoma Curr Probl Cancer 42 26-298
[5]  
Parnaby A(2016)Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review Crit Rev Oncol Hematol 99 286-1324
[6]  
Djazouli K(2010)Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy Br J Cancer 103 1318-1723
[7]  
Kleeff J(2016)Prognostic value of health-related quality of life in patients with metastatic pancreatic adenocarcinoma: a random forest methodology Qual Life Res 25 1713-29
[8]  
Korc M(2013)Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial J Clin Oncol 31 23-1112
[9]  
Apte M(2016)Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3 Pancreatology 16 1106-259
[10]  
La Vecchia C(2013)Longitudinal health-related quality of life assessment implications for prognosis in stage IV pancreatic cancer Pancreas 42 254-32